OpenAI researcher Miles Wang departs to launch $2B AI drug discovery startup
Seeking Alpha ·
OpenAI ( OPENAI ) researcher Miles Wang is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, Tech Crunch reported, citing sources familiar with the matter. Several other OpenAI (
DYAX Investor Sentiment
Bullish (Long) 45% · Bearish (Short) 55%
444 participants
Related News
- Karman gains S&P SmallCap 600 entry as BrightSpring moves up
- BYD Has Already Lapped Tesla — Now It Says Toyota Is Next And US Market Doesn't Matter
- SCHMID Group reports Q2 revenue of €27.7M; boosts full-year order targets to €125M–€150M
- BMW races to catch up in a Chinese EV market that won't slow down
- Sivadeep Katangoori: Pioneering Data Lakes, Cloud Innovation, and AI-Driven Enterprise Transformation
- 오늘 스토어브랜드 주가가 급등한 이유